Scroll to top

Scroll to top

News Releases

Home
Investors
News Releases

News Releases

Month Year

Month Year

Investor Alerts

August 12, 2019

Immunic, Inc. Announces First Patient Enrolled in Investigator-Sponsored Proof-of-Concept Clinical Trial of IMU-838 for the Treatment of Patients with Primary Sclerosing Cholangitis

- Study Being Conducted in Collaboration with Investigators at Arizona State University and the Mayo Clinic -
August 8, 2019

Immunic, Inc. Reports Second Quarter 2019 Financial Results and Highlights Recent Activity
August 1, 2019

Immunic AG Awarded Research Grant by German Federal Ministry of Education and Research in Support of the InnoMuNiCH Project
July 30, 2019

Immunic, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference on August 8
July 16, 2019

Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer

Show per page